Skip to content

Effect of esmketamine combined with ropivacaine in retrolaminar block on postoperative analgesia in patients with lumbar spinal fusion surgery

Effect of esmketamine combined with ropivacaine in retrolaminar block on postoperative analgesia in patients with lumbar spinal fusion surgery

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200058200
Enrollment
Unknown
Registered
2022-04-01
Start date
2022-05-05
Completion date
Unknown
Last updated
2023-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spine Surgery

Interventions

Group R:Ropivacaine for retrolaminar block
Group E:Mixture of Esketamine and ropivacaine for retrolaminar block

Sponsors

Lanzhou University Second Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Elective posterior Lumbar Interbody Fusion; 2. Age 18-65; 3. American Society of Anesthesiologists (ASA) Grade I-II; 4. Obtain the consent of the patient's family members before the operation, and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Contraindications of nerve block: local anesthetic allergy, coagulation disorder, puncture site damage, infection ; 2. Severe heart disease, liver insufficiency (Child-Pugh grade C) or renal insufficiency (serum creatinine > 442 umol/L or those requiring renal replacement therapy), ASA grade >= grade III or morbidly obese (BMI>30kg/m2); 3. Chronic opioid addiction or use of other analgesic drugs for more than 3 months; 4. Inability to communicate due to severe dementia, language impairment, or end-stage disease; 5. Those who refused to participate in this study, refused to use PCIA, and sign informed consent; 6. Contraindications related to esketamine Allergic to esketamine; Patients at serious risk of elevated blood pressure or intracranial pressure; Poorly controlled or untreated patients with hypertension (resting systolic/diastolic blood pressure exceeding 180/100 mmHg); Preeclampsia and eclampsia; Untreated or undertreated patients with hyperthyroidism (hyperthyroidism)Patients with mental disorders, major depression, schizophrenia or dementia.

Design outcomes

Primary

MeasureTime frame
Postoperative NRS score at rest and active movement;

Secondary

MeasureTime frame
consumption of propofol and remifentanil during surgery;First press time and total press times of postoperative analgesia pump;Postoperative sufentanil consumption;Postoperative recovery quality;Adverse reactions such as nausea, vomiting, arrhythmias, hallucinations, delirium;

Countries

China

Contacts

Public ContactWang Yingbin

Lanzhou University Second Hospital

wangyingbin6@163.com+86 13893133264

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026